DUBLIN, July 5, 2021 / PRNewswire / – The report, “Epithelial Cell Culture Media Market Forecast to 2028 – COVID-19 Impact and Global Analysis by Product Type and End User” has been added to ResearchAndMarkets.com offer.

Epithelial Cell Culture Media Market Expected To Reach US $ 303,040.33 thousand by 2028 onwards 128 155.95 thousand USD in 2020; it is estimated to increase at a CAGR of 11.36% over the period 2020-2028. The growth of the market is mainly attributed to key factors such as the increasing applications of epithelial cells and increasing funding of epithelial cell research. However, the risk of contamination, misidentification, and random alternations in cell lines is hampering the growth of the market.

Epithelial cells isolated from tracheal, bronchial, distal respiratory tract, mammary, prostatic, vaginal, cervical and renal tissues, among others, mimic the physiological state of cells in vivo. These cells are invaluable in biological research for understanding how living systems work. Cervical epithelial cells provide an in vitro model for studying physiological processes associated with diseases such as cervical cancer, cervical polyps, and human papillomavirus (HPV) disease. The 3D model epithelial cells are used in disease modeling, molecule uptake, toxicity studies, and drug discovery, among others. Cellular tests have been widely used in drug discovery for several decades. 2D models provide valuable information on early biological responses and are suitable for high throughput drug screening, but they offer poor predictive capabilities. In addition, epithelial cell lines are used in studies of drug transport processes. Epithelial cell drug transport studies can be performed easily under controlled conditions and generate important information.

Along with the increasing applications of epithelial cells, the demand for media necessary for culturing these cell lines is also increasing, which is driving the growth of the epithelial cell culture media market.

Based on the product type, the epithelial cell culture media market is segmented into human mammary epithelial cells, bronchial / tracheal epithelial cells, and renal epithelial cells. By end user, the market is segmented into biopharmaceutical companies, academic and research laboratories, and others. The biopharmaceutical company segment held the largest share of the market in 2020. Biopharmaceuticals have been the fastest growing area of ​​the pharmaceutical industry in recent years, with over 200 treatments approved and hundreds more in progress. development, while the pharmaceutical industry as a whole has struggled with single-digit growth, tighter pipelines and pressure from an increasingly aggressive generics company. This is expected to promote the growth of the market during the forecast period.

World Health Organization (WHO), National Health Service, Centers for Disease Control and Prevention (CDC), Organization for Economic Co-operation and Development (OECD), European Collection of Cell Cultures, Among the prime primary and secondary sources referred to in preparing the Epithelial Cell Culture Media Market report are the Department of Biotechnology and the China National Center for Biotechnology Development along with company websites.

Reasons to buy

  • Gain and reduce the time required to conduct entry-level research by identifying the growth, size, leading players and segments of the Epithelial Cell Culture Media market.
  • Highlights key business priorities to help companies realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global Epithelial Cell Culture Media Market, thereby enabling value chain players to develop effective long-term strategies.
  • Develop / modify business expansion plans using a substantial growth offering in developed and emerging markets.
  • Take an in-depth look at the global market trends and outlook associated with the factors driving the market, as well as those hindering it.
  • Improve decision-making by understanding the strategies that underpin security interests with respect to customer products, segmentation, pricing, and distribution.

Main topics covered:

1. Introduction

2. Epithelial Cell Culture Media Market – Key Points to Remember

3. Research methodology
3.1 Coverage
3.2 Secondary research
3.3 Primary research

4. Global Epithelial Cell Culture Media Market – Market Landscape
4.1 Overview
4.2 PEST analysis
4.2.1 North America – PEST analysis
4.2.2 Europe – PEST analysis
4.2.3 Asia Pacific – PEST analysis
4.2.4 Middle East and Africa (MEA) – PEST Analysis
4.2.5 South and central America (SCAM) – PEST Analysis
4.3 Expert advice

5. Epithelial Cell Culture Media Market – Key Market Dynamics
5.1 Market drivers
5.1.1 Growing Applications of Epithelial Cells
5.1.2 Increased funding for epithelial cell research
5.2 Market restrictions
5.2.1 Risk of contamination, misidentification and random alternations in cell lines
5.3 Market opportunities
5.3.1 Thriving biopharmaceutical industries in different countries
5.4 Future trends
5.4.1 Adoption of regenerative drugs
5.5 Impact analysis

6.Epithelial Cell Culture Media Market – Global Analysis
6.1 Global Epithelial Cell Culture Media Market Forecast and Revenue Analysis
6.2 Global Epithelial Cell Culture Media Market, By Geography – Forecast and Analysis
6.3 Market positioning of key players

7. Epithelial Cell Culture Media Market Analysis – By Product Type
7.1 Overview
7.2 Epithelial Cell Culture Media Market Revenue Share, by Product Type (2020 and 2028)
7.3 Human breast epithelial cells
7.3.1 Overview
7.3.2 Human Mammary Epithelial Cells: Epithelial Cell Culture Media Market – Revenue and Forecast to 2028 (Thousands of US $)
7.4 Bronchial / tracheal epithelial cells
7.4.1 Overview
7.4.2 Bronchial / Tracheal Epithelial Cells: Epithelial Cell Culture Media Market – Revenue and Forecast to 2028 (Thousands of US $)
7.5 Renal epithelial cells
7.5.1 Overview
7.5.2 Renal Epithelial Cells: Epithelial Cell Culture Media Market Revenue and Forecast to 2028 (Thousands of US $)
7.6 Others
7.6.1 Overview
7.6.2 Others: Epithelial Cell Culture Media Market Revenue and Forecast to 2028 (Thousands of US $)

8. Epithelial Cell Culture Media Market Analysis – By End User
8.1 Overview
8.2 Epithelial Cell Culture Media Market Revenue Share, by End User (2020 and 2028)
8.3 Biopharmaceutical companies
8.3.1 Biopharmaceutical Companies: Epithelial Cell Culture Media Market – Revenue and Forecast to 2028 (Thousands of US $)
8.4 University and research laboratories
8.4.1 Overview
8.4.2 Academic and Research Laboratories: Epithelial Cell Culture Media Market – Revenue and Forecast to 2028 (Thousands of US $)
8.5 Others
8.5.1 Overview
8.5.2 Others: Epithelial Cell Culture Media Market Revenue and Forecast to 2028 (Thousands of US $)

9. Epithelial Cell Culture Media Market – Geographic Analysis

10. Impact of the COVID-19 pandemic on the global epithelial cell culture media market
10.1 North America: Assessment of the impact of the COVID-19 pandemic
10.2 Europe: Assessment of the impact of the COVID-19 pandemic
10.3 Asia Pacific: Assessment of the impact of the COVID-19 pandemic
10.4 Middle East and Africa: Assessment of the impact of the COVID-19 pandemic
10.5 South and central America: Assessment of the impact of the COVID-19 pandemic

11. Epithelial Cell Culture Media Market and Industry Landscape
11.2 Organic and inorganic developments
11.2.1 Presentation

12. Company profiles
12.1 Thermo Fisher Scientific Inc.
12.1.1 Key facts
12.1.2 Company description
12.1.3 Products and services
12.1.4 Financial overview
12.1.5 SWOT Analysis
12.1.6 Key developments
12.2 PromoCell GmbH
12.2.1 Key facts
12.2.2 Company description
12.2.3 Products and services
12.2.4 Financial overview
12.2.5 SWOT Analysis
12.2.6 Key developments
12.3 MERCK KGaA
12.3.1 Key facts
12.3.2 Company description
12.3.3 Products and services
12.3.4 Financial overview
12.3.5 SWOT Analysis
12.3.6 Key developments
12.4 ATCC
12.4.1 Key facts
12.4.2 Company description
12.4.3 Products and services
12.4.4 Financial overview
12.4.5 SWOT Analysis
12.4.6 Key developments
12.5 Axol Bioscience Ltd.
12.5.1 Key facts
12.5.2 Company description
12.5.3 Products and services
12.5.4 Financial overview
12.5.5 SWOT Analysis
12.5.6 Key developments
12.6 Celprogen, Inc
12.6.1 Key facts
12.6.2 Company description
12.6.3 Products and services
12.6.4 Financial overview
12.6.5 SWOT Analysis
12.6.6 Key developments
12.7 Lonza
12.7.1 Key facts
12.7.2 Company description
12.7.3 Products and services
12.7.4 Financial overview
12.7.5 SWOT Analysis
12.7.6 Key developments
12.8 HiMedia Laboratories
12.8.1 Key facts
12.8.2 Company description
12.8.3 Products and services
12.8.4 Financial overview
12.8.5 SWOT Analysis
12.8.6 Key developments
12.9 Cellular biologics
12.9.1 Key facts
12.9.2 Company description
12.9.3 Products and services
12.9.4 Financial overview
12.9.5 SWOT Analysis
12.9.6 Key developments
12.10 BIOTECHNICAL COMPANY
12.10.1 Key facts
12.10.2 Company description
12.10.3 Products and services
12.10.4 Financial overview
12.10.5 SWOT Analysis
12.10.6 Key developments

13. Annex

For more information on this report, visit https://www.researchandmarkets.com/r/y21z7y

Media contact:

Research and markets
Laura Wood, senior
[email protected]

For EST office hours, call + 1-917-300-0470
For USA / CAN call toll free + 1-800-526-8630
For GMT office hours, call + 353-1-416-8900

US Fax: 646-607-1907
Fax (outside the United States): + 353-1-481-1716

SOURCE Research and Markets

Related links

http://www.researchandmarkets.com



Source link